A Study of Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP Inhibitor
Phase NA Terminated
5 enrolled
Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada
Terminated
24 enrolled
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma
Phase 2 Terminated
9 enrolled 10 charts
TILsOV
Phase NA Terminated
36 enrolled
ACCRAPAN
Phase 2 Terminated
21 enrolled
GEMCOL
Phase 2 Terminated
19 enrolled
ANOXICOL
Phase NA Terminated
9 enrolled
Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer
Phase 1/2 Terminated
5 enrolled
Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal Carcinomatosis
Phase 1 Terminated
4 enrolled
FAB
Phase 2 Terminated
27 enrolled
Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations
Phase 2 Terminated
7 enrolled 10 charts
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
Phase NA Terminated
137 enrolled 15 charts
BASICS
Phase NA Terminated
3 enrolled
ENDOCOL
Phase NA Terminated
3 enrolled
Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP
Phase 2/3 Terminated
12 enrolled
MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer
Phase 2 Terminated
17 enrolled 14 charts
A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors
Phase 1 Terminated
31 enrolled
Identification and Prevention of Pelvic Floor Dysfunction in Gynecologic Cancer Survivors
Phase NA Terminated
22 enrolled
Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer
Phase 2 Terminated
4 enrolled 8 charts
PAIR HPV
Phase NA Terminated
26 enrolled
COCHISE
Phase 2 Terminated
18 enrolled 9 charts
MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Phase 1 Terminated
1 enrolled 5 charts
CAN-STAMP
Phase 2/3 Terminated
11 enrolled
T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer
Phase 1/2 Terminated
6 enrolled 11 charts
Effect of a Childcare Resource on Cervical Cancer Prevention
Phase NA Terminated
65 enrolled
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
Phase 1/2 Terminated
19 enrolled
Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer
Phase 2 Terminated
40 enrolled
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer
Phase NA Terminated
409 enrolled
AM-003
Phase 1 Terminated
5 enrolled
Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines
Phase 1/2 Terminated
25 enrolled
The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach
Phase 2 Terminated
2 enrolled
Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients
Phase 3 Terminated
62 enrolled 16 charts
Exercise Preconditioning in Ovarian Cancer
Phase NA Terminated
8 enrolled
AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 1/2 Terminated
12 enrolled 13 charts
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
Phase 1 Terminated
221 enrolled
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
Phase 1 Terminated
16 enrolled
Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
Phase 1 Terminated
33 enrolled
NIRAPK
Phase 4 Terminated
12 enrolled
IMMUVIX
Phase 2 Terminated
29 enrolled
KYSTOV
Phase NA Terminated
105 enrolled
SCC-BAREDU
Terminated
26 enrolled
Auranofin and Sirolimus in Treating Participants With Ovarian Cancer
Phase 2 Terminated
22 enrolled 9 charts
Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 2 Terminated
1 enrolled 5 charts
HPVAC2
Terminated
354 enrolled
Pembrolizumab and Olaparib in Cervical Cancer Patients
Phase 2 Terminated
8 enrolled 13 charts
PEDD-UFE
Phase NA Terminated
3 enrolled
Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging
Phase 1/2 Terminated
7 enrolled 9 charts
ORGANOIDES
Phase NA Terminated
14 enrolled
Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma
Phase 2 Terminated
16 enrolled 11 charts
IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3
Phase 2 Terminated
10 enrolled 19 charts